JP2009508476A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009508476A5 JP2009508476A5 JP2008529350A JP2008529350A JP2009508476A5 JP 2009508476 A5 JP2009508476 A5 JP 2009508476A5 JP 2008529350 A JP2008529350 A JP 2008529350A JP 2008529350 A JP2008529350 A JP 2008529350A JP 2009508476 A5 JP2009508476 A5 JP 2009508476A5
- Authority
- JP
- Japan
- Prior art keywords
- cell line
- antibody
- polypeptide
- produced
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71305505P | 2005-08-31 | 2005-08-31 | |
| US71285805P | 2005-08-31 | 2005-08-31 | |
| PCT/US2006/034382 WO2007028106A2 (en) | 2005-08-31 | 2006-08-31 | Host cell lines for production of antibody constant region with enhanced effector function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009508476A JP2009508476A (ja) | 2009-03-05 |
| JP2009508476A5 true JP2009508476A5 (enExample) | 2009-09-24 |
Family
ID=37809622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008529350A Pending JP2009508476A (ja) | 2005-08-31 | 2006-08-31 | 高められたエフェクター機能をもつ抗体定常領域の製造用の宿主細胞株 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20090214528A1 (enExample) |
| EP (1) | EP1937313A4 (enExample) |
| JP (1) | JP2009508476A (enExample) |
| KR (1) | KR20080048505A (enExample) |
| AU (1) | AU2006287224A1 (enExample) |
| BR (1) | BRPI0616600A2 (enExample) |
| CA (1) | CA2621236A1 (enExample) |
| MX (1) | MX2008003054A (enExample) |
| WO (1) | WO2007028106A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1176195E (pt) | 1999-04-09 | 2013-07-18 | Kyowa Hakko Kirin Co Ltd | Processo para controlar a actividade de uma molécula funcional sob o ponto de vista imunológico |
| FR2807767B1 (fr) * | 2000-04-12 | 2005-01-14 | Lab Francais Du Fractionnement | Anticorps monoclonaux anti-d |
| US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| SG176088A1 (en) * | 2009-05-29 | 2011-12-29 | Glaxosmithkline Llc | Methods of administration of thrombopoietin agonist compounds |
| EP3715356B1 (en) * | 2009-12-18 | 2023-10-11 | CSL Limited | Method of purifying polypeptides |
| GB201003701D0 (en) * | 2010-03-05 | 2010-04-21 | Cilian Ag | System for the expression of a protein |
| EP2791171A1 (en) | 2011-12-16 | 2014-10-22 | Synthon Biopharmaceuticals B.V. | EXPRESSION OF SECRETORY IgA ANTIBODIES IN DUCKWEED |
| KR102096014B1 (ko) | 2012-12-05 | 2020-04-03 | 알닐람 파마슈티칼스 인코포레이티드 | PCSK9 iRNA 조성물 및 그 사용 방법 |
| US9217168B2 (en) | 2013-03-14 | 2015-12-22 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| US9677105B2 (en) | 2013-03-14 | 2017-06-13 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| US8956830B2 (en) | 2013-03-14 | 2015-02-17 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| DK3149045T3 (da) * | 2014-05-27 | 2023-03-06 | Academia Sinica | Sammensætninger og fremgangsmåder vedrørende universelle glycoformer til forbedret antistofeffekt |
| MX2018002158A (es) * | 2015-08-25 | 2018-07-06 | Alnylam Pharmaceuticals Inc | MíTODOS Y COMPOSICIONES PARA TRATAR UN TRASTORNO ASOCIADO A GEN DE PROPROTEINA CONVERTASA SUBTILISINA KEXINA (PCSK9). |
| US10465003B2 (en) * | 2016-02-05 | 2019-11-05 | Janssen Biotech, Inc. | Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes |
| JP2020506916A (ja) | 2017-01-30 | 2020-03-05 | ヤンセン バイオテツク，インコーポレーテツド | 活動性乾癬性関節炎の治療のための抗ｔｎｆ抗体、組成物、及び方法 |
| EP3579871A4 (en) | 2017-02-07 | 2021-07-21 | Janssen Biotech, Inc. | ANTI-TNF ANTIBODIES, COMPOSITIONS, AND METHODS OF TREATMENT FOR ACTIVE BECHTEREW'S LIVER |
| KR102323342B1 (ko) * | 2019-04-26 | 2021-11-08 | 주식회사 와이바이오로직스 | IL-17A 및 TNF-α에 특이적으로 결합하는 이중표적 항체 |
| AU2020267953A1 (en) * | 2019-05-08 | 2021-11-18 | Novartis Ag | Anti-CD40 antibodies for use in treatment of T1DM and insulitis |
| US11780911B2 (en) | 2019-05-23 | 2023-10-10 | Janssen Biotech, Inc. | Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha |
| MX2022014430A (es) | 2020-05-21 | 2023-02-22 | Janssen Biotech Inc | Método para tratar la enfermedad inflamatoria del intestino con una terapia de combinación de anticuerpos para il-23 y tnf alfa. |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1079704A (en) | 1912-06-19 | 1913-11-25 | Dallas C Hathaway | Combination tire valve-stem and pressure-gage. |
| DE3167442D1 (en) * | 1980-07-07 | 1985-01-10 | Nat Res Dev | Improvements in or relating to cell lines |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4816597A (en) * | 1983-10-02 | 1989-03-28 | New Jersey Institute Of Technology | Dental restorative materials based upon blocked isocyanates |
| GB8421551D0 (en) | 1984-08-24 | 1984-09-26 | Ici Plc | Water-soluble dye |
| ATE266726T1 (de) | 1995-06-07 | 2004-05-15 | Ortho Pharma Corp | CDR-TRANSPLANTIERTE ANTIKÖRPER GEGEN ßTISSUE FACTORß UND VERFAHREN ZUR DEREN VERWENDUNG |
| NZ336780A (en) | 1997-01-16 | 2000-12-22 | Neose Technologies Inc | In vitro sialylation of glycoproteins |
| AU3657899A (en) * | 1998-04-20 | 1999-11-08 | James E. Bailey | Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| PT1176195E (pt) * | 1999-04-09 | 2013-07-18 | Kyowa Hakko Kirin Co Ltd | Processo para controlar a actividade de uma molécula funcional sob o ponto de vista imunológico |
| UA81743C2 (uk) | 2000-08-07 | 2008-02-11 | Центокор, Инк. | МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ |
| US6946292B2 (en) * | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| CA2438148A1 (en) | 2001-02-15 | 2002-08-29 | Centocor, Inc. | Chemically defined medium for cultured mammalian cells |
| EP1502603A4 (en) * | 2002-04-09 | 2006-12-13 | Kyowa Hakko Kogyo Kk | AN ANTIBODY COMPOSITION CONTAINING MEDICAMENT FOR PATIENTS WITH Fc gamma RIIIa POLYMORPHISM |
| US20040110704A1 (en) * | 2002-04-09 | 2004-06-10 | Kyowa Hakko Kogyo Co., Ltd. | Cells of which genome is modified |
| CA2481837A1 (en) | 2002-04-09 | 2003-10-16 | Kyowa Hakko Kogyo Co., Ltd. | Production process for antibody composition |
| US7605235B2 (en) * | 2003-05-30 | 2009-10-20 | Centocor, Inc. | Anti-tissue factor antibodies and compositions |
| EP1633309A4 (en) * | 2003-05-30 | 2007-06-13 | Centocor Inc | METHOD FOR INHIBITING TUMOR GROWTH WITH ANTI-TISSUE FACTOR ANTIBODIES |
-
2006
- 2006-08-31 WO PCT/US2006/034382 patent/WO2007028106A2/en not_active Ceased
- 2006-08-31 CA CA002621236A patent/CA2621236A1/en not_active Abandoned
- 2006-08-31 AU AU2006287224A patent/AU2006287224A1/en not_active Abandoned
- 2006-08-31 JP JP2008529350A patent/JP2009508476A/ja active Pending
- 2006-08-31 BR BRPI0616600-8A patent/BRPI0616600A2/pt not_active Application Discontinuation
- 2006-08-31 US US12/065,178 patent/US20090214528A1/en not_active Abandoned
- 2006-08-31 EP EP06814116A patent/EP1937313A4/en not_active Withdrawn
- 2006-08-31 KR KR1020087007406A patent/KR20080048505A/ko not_active Ceased
- 2006-08-31 MX MX2008003054A patent/MX2008003054A/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12084496B2 (en) | Anti-ROR antibody constructs | |
| TWI586686B (zh) | 胰高血糖素受體之人類抗體 | |
| EP3561058B1 (en) | Fusion protein including bdnf | |
| BR112020026862A2 (pt) | antagonistas antitumorais de reguladores de pontos de verificação imunológica | |
| CN107217042A (zh) | 一种生产无岩藻糖基化蛋白的基因工程细胞系及其建立方法 | |
| JP2008537874A5 (enExample) | ||
| CN111601821B (zh) | 具有对FcRn的亲和力提高以及对至少一个Fc片段受体的亲和力提高的Fc片段的变体 | |
| TW200415241A (en) | Fc fusion proteins of human erythropoietin with high biological activities | |
| JP2008515446A5 (enExample) | ||
| AU2016341409B2 (en) | Single-chain CD27-receptor agonist proteins | |
| CA2663042A1 (en) | Serum albumin binding proteins with long half-lives | |
| TW201348247A (zh) | 利用蛋白質ａ親和性層析之非人類抗體之新穎純化 | |
| CA3002588C (en) | Single-chain cd137-receptor agonist proteins | |
| JP2014530001A5 (enExample) | ||
| JPH01502669A (ja) | 精製された血小板由来の成長因子及びその精製方法 | |
| CN106232135B (zh) | Uti融合蛋白 | |
| AU2019327493A1 (en) | Combination therapies comprising sirp alpha-based chimeric proteins | |
| WO2015172305A1 (zh) | 抑制taci-baff复合物形成的融合蛋白及其制法和用途 | |
| CN105820248A (zh) | 一种新型抗egfr单克隆抗体的制备方法及应用 | |
| JP2018533948A (ja) | 一本鎖ｌｉｇｈｔ受容体アゴニストタンパク質 | |
| JP2010512306A5 (enExample) | ||
| CN119907811A (zh) | 针对cd28的多功能分子 | |
| CA3003511A1 (en) | Single-chain tl1a receptor agonist proteins | |
| TW201945392A (zh) | Gcgr抗體及其與glp-1的融合蛋白質，以及其藥物組合物和應用 | |
| WO2022143516A1 (zh) | 一种人glp-1多肽变体及其应用 |